TD Private Client Wealth LLC Sells 219,209 Shares of Kenvue Inc. $KVUE

TD Private Client Wealth LLC lowered its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 80.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 51,993 shares of the company’s stock after selling 219,209 shares during the quarter. TD Private Client Wealth LLC’s holdings in Kenvue were worth $844,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the business. Nordea Investment Management AB lifted its holdings in shares of Kenvue by 13.1% in the 3rd quarter. Nordea Investment Management AB now owns 188,185 shares of the company’s stock valued at $3,050,000 after acquiring an additional 21,790 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. raised its position in Kenvue by 2.3% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 64,240 shares of the company’s stock valued at $1,043,000 after purchasing an additional 1,436 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Kenvue by 0.9% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,906,600 shares of the company’s stock valued at $79,634,000 after purchasing an additional 44,946 shares during the last quarter. First Horizon Corp purchased a new position in shares of Kenvue in the 3rd quarter worth approximately $339,000. Finally, Sterneck Capital Management LLC boosted its holdings in shares of Kenvue by 12.4% in the 3rd quarter. Sterneck Capital Management LLC now owns 41,732 shares of the company’s stock worth $677,000 after purchasing an additional 4,591 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

KVUE has been the topic of several recent research reports. Barclays increased their price target on Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Deutsche Bank Aktiengesellschaft set a $18.00 target price on shares of Kenvue in a research note on Friday, October 24th. Johnson Rice reaffirmed a “neutral” rating on shares of Kenvue in a research note on Tuesday, October 28th. Citigroup reduced their price objective on shares of Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, October 9th. Finally, Edward Jones downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat.com, Kenvue has an average rating of “Hold” and a consensus price target of $20.23.

Kenvue Trading Up 0.8%

NYSE KVUE opened at $17.27 on Friday. The stock has a market cap of $33.08 billion, a PE ratio of 23.02 and a beta of 0.60. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The company’s 50-day moving average price is $16.97 and its 200-day moving average price is $18.31. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.01. The company had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The firm’s quarterly revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Investors of record on Wednesday, November 12th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue’s dividend payout ratio is 110.67%.

Insider Buying and Selling

In other news, Director Jeffrey C. Smith acquired 3,200,000 shares of Kenvue stock in a transaction on Friday, December 12th. The shares were bought at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.68% of the stock is owned by insiders.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.